
Young researchers must shoulder responsibility of developing low-cost treatment for rare diseases: Niti Aayog member
The HinduLauding significant milestones in India’s genetic research journey, V.K. Paul, NITI Aayog member, on Monday called upon young researchers to shoulder the responsibility of furthering the country’s contributions in developing low-cost treatments for rare as well as other genetic diseases. Dr. Paul emphasised landmark contributions by Indian geneticists in discovering novel gene therapies for Sickle Cell Disease and small molecules for the treatment of some other rare genetic diseases. Highlighting national collaborations that addressed rare genetic conditions, Dr. Paul announced the availability of life-saving drugs for thalassemia, Gaucher disease, Wilson’s disease, and sickle cell disease in children. Speaking on the genetic basis of brain disorders, particularly Autism Spectrum Disorder, Dr. Murthy said collaborative research under initiatives such as Accelerator Program for Discovery in Brain Disorders using stem cells, a programme funded by the Department of Biotechnology is crucial for advancing rare disease treatments.
History of this topic

Over 70 million Indians living with rare diseases but challenges remain
India Today
NIMS Data Shows Fivefold Rise in Rare Genetic Disease Cases Over a Decade
Deccan Chronicle
Despite decades of advocacy, and govt backing, care for rare diseases not optimal
The Hindu
K.C. Deepika on rare diseases in India
The Hindu
Infosys Prize-winning chemist Dr Yamuna Krishnan on her work with DNA, and science in India
Firstpost
Need to understand rare diseases: Kalam
The HinduDiscover Related










































